Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
More stories
Mitchell
News Release
FDA Approves Higher Dose Naloxone, Kloxxado
Naloxone has been known by different brand names over the years as the primary treatment of opioid overdose.
Genex
News Release
Mitchell | Genex | Coventry Signs Agreement to Acquire QualCare Alliance Networks Inc.
Deal will strengthen company's network in New Jersey
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Genex
Blog
Self-service tools can bring savings for both payers and providers
The phone in your pocket shouldn’t really be called a phone, should it? After all, making calls isn’t its primary purpose.
Mitchell
News Release
Mitchell Teams With Mazda North American Operations to Launch U.S. Collision Repair Network
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the